MedTrace Logo

Preauthorization Versus Prospective Audit in Antimicrobial Stewardship Program

NCT02837081 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1060

Last updated 2016-07-19

No results posted yet for this study

Summary

Antimicrobial stewardship program (ASP) is recommended to improve appropriate antimicrobial use, reduce bacterial resistance, unnecessary drug costs and enhance patient health outcomes. Two core strategies of ASP recommended as effective in guidelines are formulary restriction with drug preauthorization and prospective audit with feedback. Investigators will evaluate the effectiveness of the 2 strategies using antimicrobial utilization and patient outcomes.

Conditions

Interventions

OTHER

Prospective audit strategy of antimicrobial stewardship

applying prospective audit as a different strategy of antimicrobial stewardship

OTHER

preauthorization strategy of antimicrobial stewardship

applying preauthorization as one strategy of antimicrobial stewardship

Sponsors & Collaborators

  • Kaohsiung Veterans General Hospital.

    lead OTHER

Principal Investigators

  • Susan Shin-Jung Lee, M.D., Ph.D. · Kaohsiung Veterans General Hospital.

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-12-31
Completion
2017-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02837081 on ClinicalTrials.gov